TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
Technical Sentiment
Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting TransCode Therapeutics is a Buy.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 9.21, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Sell.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 9.36, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Sell.
TransCode Therapeutics (RNAZ) Pivot Points
Classic
8.07
8.29
8.42
8.64
8.77
8.99
9.12
Fibonacci
8.29
8.43
8.51
8.64
8.78
8.86
8.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
TransCode Therapeutics (RNAZ) Moving Averages
MA5
8.66Buy
8.72Sell
MA10
9.01Sell
8.94Sell
MA20
9.38Sell
9.21Sell
MA50
9.62Sell
9.36Sell
MA100
9.07Sell
9.49Sell
MA200
9.85Sell
9.78Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 8.94, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Sell.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 9.49, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $6.96 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 9.62, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.96 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 9.07, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.96 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 9.85, creating a Sell signal.
TransCode Therapeutics (RNAZ) Technical Indicators
RSI (14)
41.63
Neutral
STOCH (9,6)
13.99
Buy
STOCHRSI (14)
12.09
Buy
MACD (12,26)
-0.26
Buy
ADX (14)
17.29
Buy
Williams %R
-81.13
Buy
CCI (14)
-100.25
Buy
ATR (14)
0.67
-
Ultimate Oscillator
33.81
Neutral
ROC
-10.03
Sell
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 41.63, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 17.29, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is -100.25, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is -10.03, creating a Sell signal.
FAQ
Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Sell.
What is RNAZ’s RSI (14)?
RNAZ’s RSI (14) is 41.63, which suggests RNAZ is a Neutral.
What is RNAZ’s MACD?
RNAZ’s MACD is -0.26, which suggests RNAZ is a Buy.
What is RNAZ’s 5-day moving average?
RNAZ’s 5-day moving average is 8.66, which suggests RNAZ is a Buy.
What is RNAZ’s 20-day moving average?
RNAZ 20-day moving average is 9.38, which suggests RNAZ is a Sell.
What is RNAZ’s 50-day moving average?
RNAZ’s 50-day moving average is 9.62, which suggests RNAZ is a Sell.
What is RNAZ’s 200-day moving average?
RNAZ’s 200-day moving average is 9.85, which suggests RNAZ is a Sell.
What is RNAZ’s Williams % R (14)?
RNAZ’s Williams % R (14) is -81.13, which suggests RNAZ is a Buy.
What is RNAZ’s CCI (14)?
RNAZ’s CCI (14) is -100.25, which suggests RNAZ is a Buy.